Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLUANASDAQ:CLPTNASDAQ:OMNASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUABlueRiver Acquisition$11.09$10.26▼$11.45$96.90MN/A26,528 shs16,400 shsCLPTClearPoint Neuro$11.79-0.2%$12.66$5.11▼$19.22$331.53M1.03235,696 shs151,657 shsOMOutset Medical$17.87+1.7%$13.40$5.85▼$72.60$316.69M1.9109,036 shs140,351 shsTMCITreace Medical Concepts$5.73-0.3%$6.98$4.54▼$10.79$360.11M0.79592,917 shs260,695 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUABlueRiver Acquisition0.00%0.00%0.00%0.00%+0.54%CLPTClearPoint Neuro0.00%-0.67%-18.16%-12.84%+117.50%OMOutset Medical0.00%-1.11%+44.90%+77.23%-68.28%TMCITreace Medical Concepts0.00%-2.04%-20.66%-34.25%-2.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUABlueRiver AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACLPTClearPoint Neuro2.0089 of 5 stars3.52.00.00.03.20.00.6OMOutset Medical2.5098 of 5 stars3.55.00.00.02.40.80.0TMCITreace Medical Concepts2.1821 of 5 stars3.11.00.00.01.74.20.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUABlueRiver Acquisition 0.00N/AN/AN/ACLPTClearPoint Neuro 3.00Buy$25.00112.03% UpsideOMOutset Medical 3.00Buy$27.0051.09% UpsideTMCITreace Medical Concepts 2.29Hold$10.1677.42% UpsideCurrent Analyst Ratings BreakdownLatest BLUA, TMCI, CLPT, and OM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025OMOutset MedicalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.005/15/2025OMOutset MedicalScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/9/2025TMCITreace Medical ConceptsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.605/8/2025OMOutset MedicalRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.004/11/2025TMCITreace Medical ConceptsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$9.50 ➝ $8.004/1/2025CLPTClearPoint NeuroStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $25.003/21/2025OMOutset MedicalStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$15.003/13/2025TMCITreace Medical ConceptsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $9.503/3/2025TMCITreace Medical ConceptsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$8.40 ➝ $10.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUABlueRiver AcquisitionN/AN/AN/AN/A($0.72) per shareN/ACLPTClearPoint Neuro$32.24M10.24N/AN/A$0.86 per share13.71OMOutset Medical$115.27M2.75N/AN/A$2.45 per share7.29TMCITreace Medical Concepts$210.82M1.71N/AN/A$2.24 per share2.56Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUABlueRiver Acquisition-$5.28MN/A0.00N/AN/AN/AN/A-34.53%N/ACLPTClearPoint Neuro-$22.09M-$0.76N/AN/AN/A-59.64%-62.10%-38.39%8/6/2025 (Estimated)OMOutset Medical-$172.80M-$29.15N/A∞N/A-112.57%-175.64%-38.61%8/6/2025 (Estimated)TMCITreace Medical Concepts-$49.53M-$0.85N/AN/AN/A-30.33%-51.12%-26.36%8/5/2025 (Estimated)Latest BLUA, TMCI, CLPT, and OM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025CLPTClearPoint Neuro-$0.15-$0.22-$0.07-$0.22$8.21 million$8.49 million5/8/2025Q1 2025TMCITreace Medical Concepts-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million5/7/2025Q1 2025OMOutset Medical-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUABlueRiver AcquisitionN/AN/AN/AN/AN/ACLPTClearPoint NeuroN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUABlueRiver AcquisitionN/A0.010.01CLPTClearPoint NeuroN/A4.543.61OMOutset Medical4.126.495.04TMCITreace Medical Concepts0.514.122.98Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUABlueRiver Acquisition22.34%CLPTClearPoint Neuro30.08%OMOutset MedicalN/ATMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipBLUABlueRiver Acquisition78.98%CLPTClearPoint Neuro6.97%OMOutset Medical2.40%TMCITreace Medical Concepts27.72%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLUABlueRiver Acquisition38.73 million1.84 millionNot OptionableCLPTClearPoint Neuro11027.99 million25.90 millionOptionableOMOutset Medical52017.72 million51.50 millionNot OptionableTMCITreace Medical Concepts25062.89 million47.08 millionOptionableBLUA, TMCI, CLPT, and OM HeadlinesRecent News About These CompaniesTreace Medical Concepts, Inc. (TMCI) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before June 10, 2025June 2 at 1:30 PM | accessnewswire.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace MedicalJune 2 at 1:09 PM | globenewswire.comJune 10, 2025 Deadline: Join Class Action Lawsuit Against Treace Medical Concepts, Inc. (TMCI) - Contact Levi & KorsinskyJune 2 at 12:30 PM | accessnewswire.comLost Money on Treace Medical Concepts, Inc. (TMCI)? Join Class Action Before June 10, 2025 - Contact Levi & KorsinskyJune 2 at 11:45 AM | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Treace Medical Concepts, Inc. - TMCIJune 2 at 11:25 AM | globenewswire.comSecurities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky Before June 10, 2025June 2 at 10:15 AM | accessnewswire.comClass Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 DeadlineJune 2 at 8:25 AM | accessnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)June 2 at 8:00 AM | accessnewswire.comInvestors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025June 2 at 7:30 AM | accessnewswire.comTMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!June 2 at 7:00 AM | accessnewswire.comNuveen Asset Management LLC Has $3.52 Million Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)June 2 at 3:58 AM | marketbeat.comMillennium Management LLC Has $2.45 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)June 2 at 3:43 AM | marketbeat.comSecurities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025June 1 at 5:45 PM | accessnewswire.comTMCI DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action - TMCIJune 1 at 5:17 PM | accessnewswire.comTMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. ...June 1 at 11:20 AM | gurufocus.comTMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsJune 1 at 10:02 AM | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCIJune 1 at 10:00 AM | prnewswire.comDid You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi & Korsinsky Urges Investors to Act Before June 10, 2025June 1 at 9:45 AM | accessnewswire.comClass Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 DeadlineJune 1 at 7:30 AM | accessnewswire.comTMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!June 1 at 7:00 AM | accessnewswire.comClass Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 DeadlineMay 31 at 6:01 PM | accessnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBLUA, TMCI, CLPT, and OM Company DescriptionsBlueRiver Acquisition NYSE:BLUABlueRiver Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of technology, media, telecom, and entertainment industries. The company was incorporated in 2020 and is based in San Antonio, Texas.ClearPoint Neuro NASDAQ:CLPT$11.79 -0.02 (-0.16%) As of 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.Outset Medical NASDAQ:OM$17.87 +0.30 (+1.71%) As of 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Treace Medical Concepts NASDAQ:TMCI$5.72 -0.02 (-0.26%) As of 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Ackman Takes a Swing at Amazon — Should You? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
